Profil
Bo Ren Xue is the founder of ACT Genomics Co. Ltd. Mr. Xue is currently President, Chief Operating Officer & Director at AnBogen Therapeutics, Inc. since 2022.
Mr. Xue is also Vice President-Corporate Operations at TaiGen Biotechnology Co., Ltd. since 2001.
Formerly, Mr. Xue was President at AnBogen Therapeutics, Inc. Mr. Xue earned an MBA from Fairleigh Dickinson University in 1997 and completed undergraduate studies at Soochow University.
Postes actifs de Bo Ren Xue
| Sociétés | Poste | Début |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | President | 01/05/2022 |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Directeur des opérations | 02/10/2012 |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Fondateur | - |
Anciens postes connus de Bo Ren Xue
| Sociétés | Poste | Fin |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | President | - |
Formation de Bo Ren Xue
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Health Technology |
Soochow University
Soochow University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Health Services |
AnBogen Therapeutics, Inc.
AnBogen Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and sale of cancer precise medical drugs | Health Technology |
















